Cargando…
Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study
Interleukin-2 (IL2) is a cytokine that can stimulate cytotoxic immune cells to attack infected and malignant cells. Unfortunately, IL2 can also cause serious immune-related toxicity. Recently, a mutant of IL2 (IL2v) with abolished CD25 binding, increased plasma half-life and less toxicity was engine...
Autores principales: | Hartimath, Siddesh V., Manuelli, Valeria, Zijlma, Rolf, Signore, Alberto, Nayak, Tapan K., Freimoser-Grundschober, Anne, Klein, Christian, Dierckx, Rudi A.J.O., de Vries, Erik F.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805544/ https://www.ncbi.nlm.nih.gov/pubmed/29467958 http://dx.doi.org/10.18632/oncotarget.23852 |
Ejemplares similares
-
PET Imaging with S-[(11)C]Methyl-L-Cysteine and L-[Methyl-(11)C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation
por: Parente, Andrea, et al.
Publicado: (2017) -
Methods for Radiolabelling Nanoparticles: PET Use (Part 2)
por: Bentivoglio, Valeria, et al.
Publicado: (2022) -
Molecular imaging of hypoxia with radiolabelled agents
por: Mees, Gilles, et al.
Publicado: (2009) -
Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation
por: Di Gialleonardo, Valentina, et al.
Publicado: (2012) -
Isotopic Radiolabeling of the Antiretroviral Drug [(18)F]Dolutegravir for Pharmacokinetic PET Imaging
por: Tisseraud, Marion, et al.
Publicado: (2022)